Cell Biotech Co Ltd
KOSDAQ:049960
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kempower Oyj
OMXH:KEMPOWR
|
FI |
Cell Biotech Co Ltd
Operating Income
Cell Biotech Co Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Cell Biotech Co Ltd
KOSDAQ:049960
|
Operating Income
₩7.9B
|
CAGR 3-Years
9%
|
CAGR 5-Years
17%
|
CAGR 10-Years
-8%
|
|
|
Celltrion Inc
KRX:068270
|
Operating Income
₩1.2T
|
CAGR 3-Years
22%
|
CAGR 5-Years
10%
|
CAGR 10-Years
17%
|
|
|
SK Bioscience Co Ltd
KRX:302440
|
Operating Income
-₩123.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Operating Income
-₩36.3B
|
CAGR 3-Years
-50%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Operating Income
₩106.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
300%
|
CAGR 10-Years
97%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Operating Income
-₩40.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Cell Biotech Co Ltd
Glance View
Cell Biotech Co., Ltd. engages in the manufacture, research and development of probiotics lactobacillus products. The company is headquartered in Gimpo, Gyeonggi-Do. The company went IPO on 2002-12-13. The firm's products include lactic acid bacteria (LAB) powders and finished products containing LABs. Its LAB powders are used as raw materials in foods and medicines for the functions of immunization enhancement and digestion improvement. Its finished products containing LABs are used for intestinal health improvement, carcinogen inhibition, calcium supplement and others. The firm distributes its products within domestic market and to overseas markets.
See Also
What is Cell Biotech Co Ltd's Operating Income?
Operating Income
7.9B
KRW
Based on the financial report for Dec 31, 2025, Cell Biotech Co Ltd's Operating Income amounts to 7.9B KRW.
What is Cell Biotech Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
-8%
Over the last year, the Operating Income growth was 16%. The average annual Operating Income growth rates for Cell Biotech Co Ltd have been 9% over the past three years , 17% over the past five years , and -8% over the past ten years .
